retatrutide triple agonist glp-1 gip glucagon receptor Explained: How the Actually Works Retatrutide: The first-in-class investigational triple
Description
The balance among protein synthesis, degradation and folding is key to maintaining protein homeostasis and thus ensuring longevity
Frequently Asked Questions Do lipotropic injections actually help you lose weight
It is also a fit for patients who have plateaued with diet and movement alone
Retatrutide is not lawfully compoundable because it is investigational
A realistic timeline puts MHRA approval in late 2027 to mid-2028, following expected FDA approval in late 2027
Retatrutide is at least 18 months away from MHRA approval, and probably longer before its available on the NHS
